Identifying combinations of cancer markers for further study as triggers of early intervention

Biometrics

Volumn 56, Issue 4, 2000, Pages 1082-1087

  Baker, S G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biomarker; Bootstrap; Diagnostic tests; Discrimination; Early detection; Logistic regression; PSA; ROC curve; Screening; Sensitivity; Specificity; Validation

Indexed keywords

ANTIGENS; CURVE FITTING; DISEASES; SCREENING;

BOOTSTRAP; DIAGNOSTIC TESTS; DISCRIMINATION; EARLY DETECTION; LOGISTICS REGRESSIONS; PROSTATE SPECIFIC ANTIGEN; RECEIVER OPERATING CHARACTERISTIC CURVES; SENSITIVITY; SPECIFICITY; VALIDATION;

UROLOGY;

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DISEASE MARKER; EARLY DIAGNOSIS; HUMAN; PROSTATE CANCER; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 0033638552     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0006-341X.2000.01082.x     Document Type: Article

References (21)

1. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: Design, methods, participant characteristics, and compliance
2. Evaluating multiple diagnostic tests with partial verification
3. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screens
4. A leisurely look a the bootstrap, the jackknife, and cross-validation
5. Incorporating the time dimension in receiver operating characteristic curves: A Prostate Cancer Case Study
6. Report of the International Workshop on Screening for Breast Cancer
7. ROC analysis of mammography and palpation for breast screening
8. Receiver operating characteristic (ROC) methodology: The state of the art
9. Modelling strategies for improved prognostic prediction
10. Neural networks
11. Outcomes of modern screening mammography
12. Some limitations and problems of screening for cancer
13. Estimating unknown transition times using a piecewise nonlinear mixed-effects model in men with prostate cancer
14. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
15. The numerical measure of the success of predictions
16. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: Design, methods, participant characteristics, and compliance
17. Clinical prediction rules. Applications and methodologic standards
18. Tree-structured statistical methods